Ajit Pai @AjitPai
@AmerAcadPeds to @US_FDA: "strongly consider authorizing these vaccines for children ages 5-11 years based on data from the initial enrolled cohort" & "carefully consider the impact of ... further delays in the availability of vaccines for this age group." https://t.co/WaLTaX5Tn3 https://t.co/fSgXLIUKTX — PolitiTweet.org